INCR — InterCure Ltd.

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $3.97 Analyst target: $33.56 Upside: 745.34%

About InterCure Ltd.

Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries in North America, Europe, the Middle East and Africa, Asia-Pacific, and Latin America. The company is headquartered in Raleigh, North Carolina.

See the full interactive analysis & chart →

Informational only — not investment advice.